CA2508238C - Reovirus pour le traitement des neoplasies - Google Patents

Reovirus pour le traitement des neoplasies Download PDF

Info

Publication number
CA2508238C
CA2508238C CA002508238A CA2508238A CA2508238C CA 2508238 C CA2508238 C CA 2508238C CA 002508238 A CA002508238 A CA 002508238A CA 2508238 A CA2508238 A CA 2508238A CA 2508238 C CA2508238 C CA 2508238C
Authority
CA
Canada
Prior art keywords
reovirus
neoplasm
cells
cancer
administration
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
CA002508238A
Other languages
English (en)
Other versions
CA2508238A1 (fr
Inventor
Patrick W. K. Lee
James Strong
Matthew C. Coffey
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Oncolytics Biotech Inc
Original Assignee
Oncolytics Biotech Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/911,383 external-priority patent/US6110461A/en
Application filed by Oncolytics Biotech Inc filed Critical Oncolytics Biotech Inc
Publication of CA2508238A1 publication Critical patent/CA2508238A1/fr
Application granted granted Critical
Publication of CA2508238C publication Critical patent/CA2508238C/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Landscapes

  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002508238A 1997-08-13 1998-08-12 Reovirus pour le traitement des neoplasies Expired - Lifetime CA2508238C (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/911,383 US6110461A (en) 1997-08-13 1997-08-13 Reovirus for the treatment of neoplasia
US08/911,383 1997-08-13
CA002283280A CA2283280C (fr) 1997-08-13 1998-08-12 Reovirus pour le traitement des neoplasies

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
CA002283280A Division CA2283280C (fr) 1997-08-13 1998-08-12 Reovirus pour le traitement des neoplasies

Publications (2)

Publication Number Publication Date
CA2508238A1 CA2508238A1 (fr) 1999-02-25
CA2508238C true CA2508238C (fr) 2008-01-15

Family

ID=35005612

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002508238A Expired - Lifetime CA2508238C (fr) 1997-08-13 1998-08-12 Reovirus pour le traitement des neoplasies

Country Status (1)

Country Link
CA (1) CA2508238C (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013163727A1 (fr) * 2012-04-30 2013-11-07 Oncolytics Biotech Inc. Protection de virus modifiés contre des anticorps neutralisants utilisant la protéine sigma 1 de réovirus

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8491884B2 (en) 2000-05-03 2013-07-23 Oncolytics Biotech Inc. Virus clearance of neoplastic cells from mixed cellular compositions
US7306902B2 (en) 2002-06-28 2007-12-11 Oncolyties Biotech Inc. Oncolytic viruses as phenotyping agents for neoplasms

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013163727A1 (fr) * 2012-04-30 2013-11-07 Oncolytics Biotech Inc. Protection de virus modifiés contre des anticorps neutralisants utilisant la protéine sigma 1 de réovirus
WO2013163724A1 (fr) * 2012-04-30 2013-11-07 Oncolytics Biotech Inc. Protection de virus modifiés contre des anticorps neutralisants utilisant la protéine sigma 1 de réovirus

Also Published As

Publication number Publication date
CA2508238A1 (fr) 1999-02-25

Similar Documents

Publication Publication Date Title
CA2283280C (fr) Reovirus pour le traitement des neoplasies
US8709443B2 (en) Reovirus for the treatment of cellular proliferative disorders
CA2508238C (fr) Reovirus pour le traitement des neoplasies
CA2615684C (fr) Reovirus pour le traitement de troubles cellulaires proliferants
AU2004201630B2 (en) Reovirus for the treatment of cellular proliferative disorders
LEE et al. Patent 2283280 Summary
MXPA99010176A (en) Reovirus for the treatment of neoplasia
AU2007202448A1 (en) Reovirus for the treatment of cellular proliferative disorders

Legal Events

Date Code Title Description
EEER Examination request
MKEX Expiry

Effective date: 20180813